Internet Based Self-help for Problem Gambling Concerned Significant Others
Launched by KAROLINSKA INSTITUTET · Jan 25, 2024
Trial Information
Current as of June 30, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying an online self-help program designed for the loved ones of people who have problems with gambling. The program includes five different modules filled with helpful texts, videos, and exercises. It aims to provide support and guidance to these "concerned significant others" (CSOs) while comparing their experiences to those who are not currently receiving the program. The trial is not yet recruiting participants, but when it begins, it will focus on adults aged 18 and older who can read and respond in Swedish and are not experiencing gambling problems themselves.
To be eligible for this study, participants must not have received any gambling-related treatment in the last three months and should not have serious mental health issues that require different types of care. Those who join the trial can expect to engage with the online materials at their own pace and find resources to help them cope with the challenges of supporting someone with a gambling problem. This trial aims to see if this online support can make a difference for those who care about individuals struggling with gambling issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • No treatment related to the gambling during the past 3 months for the CSO
- • The CSO is at least 18 years old
- • The CSO can read and answer questions in Swedish.
- • The CSO is assessed as a non-problem gambler according to the Gambling Disorder Identification Test.
- Exclusion Criteria:
- • Displaying symptoms of severe psychiatric disorders such as psychosis or bipolar disease deemed to needed other treatment options.
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported